Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Artisanal Spirits Company sees strong demand for new collections

(Sharecast News) - Artisanal Spirits Company, the whisky seller and owner of The Scotch Malt Whisky Society (SMWS), announced on Monday that recent production innovation is being met with "encouraging demand", causing shares to rise in morning trade. The first two releases of the SMWS's new 'Creators Collection' have been warmly received by society members, with strong trading results.

The Peats Plant Collection has already generated more than £250,000 of sales, with the second Homecoming Collection providing equally as popular. The company noted particularly impressive take-up from SMWS members within the EU, with 75% selling out in this market within 24 hours.

The popularity of the first two collections has given the company confidence ahead of the US market launch this week.

"The level of demand for these initial launches is encouraging and we look forward to continuing to innovate and leveraging the future opportunity open to us to captivate a growing global community of whisky adventurers," said chief executive Andrew Dane.

The company also announced that two recent Scotch whisky distillery releases have been popular, while last year's acquisition of Single Cask Nation has performed better than expected.

"We have entered FY25 on the back of a strong set of FY24 results, on track to deliver further profitable growth in FY25 and beyond, continuing to demonstrate the strength of our pioneering model through product innovation, growing revenue diversification and efficient cost management combining to help achieve our ambition of creating a high quality, highly profitable and cash generative premium global business," Dane said.

Shares were up nearly 7% at 34.2p by 0900 GMT.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.